Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
AstraZeneca
Queensland Health
Mallinckrodt
McKinsey
Federal Trade Commission
Teva
Fuji
Julphar

Generated: May 24, 2018

DrugPatentWatch Database Preview

OMEPRAZOLE AND CLARITHROMYCIN AND AMOXICILLIN Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Omeprazole And Clarithromycin And Amoxicillin, and what generic alternatives are available?

Omeprazole And Clarithromycin And Amoxicillin is a drug marketed by Gastroentero and is included in one NDA.

The generic ingredient in OMEPRAZOLE AND CLARITHROMYCIN AND AMOXICILLIN is amoxicillin; clarithromycin; omeprazole. There are forty-five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the amoxicillin; clarithromycin; omeprazole profile page.
Summary for OMEPRAZOLE AND CLARITHROMYCIN AND AMOXICILLIN
Drug patent expirations by year for OMEPRAZOLE AND CLARITHROMYCIN AND AMOXICILLIN

US Patents and Regulatory Information for OMEPRAZOLE AND CLARITHROMYCIN AND AMOXICILLIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Gastroentero OMEPRAZOLE AND CLARITHROMYCIN AND AMOXICILLIN amoxicillin; clarithromycin; omeprazole CAPSULE, TABLET, CAPSULE, DELAYED RELEASE;ORAL 050824-001 Feb 8, 2011 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Express Scripts
Boehringer Ingelheim
Dow
Moodys
Queensland Health
McKinsey
UBS
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.